Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound sodium alginate suspension for symptom relief in gastroesophageal reflux disease
CTR20140086Phase 3Active
- Sponsor
- Hebikang
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium alginate + sodium bicarbonate + calcium carbonate in gastroesophageal reflux disease (GERD), sponsored by Hebikang. Started Apr 2014; status: active.
02
Drugs
sodium alginate + sodium bicarbonate + calcium carbonate
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on CTR20140086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140086.